Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

Cristina Maccalli; Hugues Nicolay; Filippo Capocefalo; Ester Fonsatti; Carla Chiarucci; Ornella Cutaia; Diana Giannarelli; Giorgio Parmiani; Anna Maria Di Giacomo; Michele Maio

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

【24h】

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

机译：II期NIBIT-M1研究中接受伊匹木单抗联合氟哌汀治疗的转移性黑色素瘤患者的免疫相关性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2013年第s1期|共页
作者
Cristina Maccalli; Hugues Nicolay; Filippo Capocefalo; Ester Fonsatti; Carla Chiarucci; Ornella Cutaia; Diana Giannarelli; Giorgio Parmiani; Anna Maria Di Giacomo; Michele Maio;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study [J] . Cristina Maccalli, Hugues Nicolay, Filippo Capocefalo, Journal for ImmunoTherapy of Cancer . 2013,第S1期

机译：II期NIBIT-M1研究中接受伊匹木单抗联合氟哌汀治疗的转移性黑色素瘤患者的免疫相关性
2. Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM) [J] . Réjean Lapointe, Rahima Jamal, Leon van Kempen, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：免疫性生物标志物来自伊立木单抗（IPI）与卡铂和紫杉醇（CP）的II期临床研究，用于无法切除的III或IV期转移性黑色素瘤（MM）患者
3. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): An open-label, single-arm phase 2 trial [J] . DiGiacomoA.M., AsciertoP.A., PillaL., The lancet oncology . 2012,第9期

机译：依匹莫单抗和奥美汀在晚期黑色素瘤（NIBIT-M1）患者中的应用：一项开放性单臂2期试验
4. Preliminary results of a phase I/II clinical trial using in situ photoimmunotherapy combined with imiquimod for metastatic melanoma patients [C] . Xiaosong Li, Mark F. Naylor, Robert E. Nordquist, . 2010

机译：使用原位光免疫疗法联合咪喹莫特治疗转移性黑色素瘤患者的I / II期临床试验的初步结果
5. Associating Computed Tomography (CT) Imaging Response Criteria and Texture Analysis Measurements with Survival in Patients with Metastatic Melanoma Treated with Anti-angiogenic Therapy. [D] . Gray, Mark Russell. 2014

机译：将计算机断层扫描（CT）成像反应标准和纹理分析测量值与接受抗血管生成治疗的转移性黑色素瘤患者的生存率相关联。
6. Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study [O] . Cristina Maccalli, Hugues Nicolay, Filippo Capocefalo, 2013

机译：Ⅱ期NIBIT-M1研究中接受伊匹木单抗联合莫司汀治疗的转移性黑色素瘤患者的免疫相关性
7. Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study [O] . 2013

机译：Ⅱ期NIBIT-M1研究中接受伊匹木单抗联合莫司汀治疗的转移性黑色素瘤患者的免疫相关性

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

著录项

相似文献

相关主题

期刊订阅